A closer look at Spravato/Esketamine. This episode focuses on the definition of Treatment Resistant Depression and looks at whether patients must be prescribed to an antidepressant while using Spravato. Additionally, what does one do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc?
KWC featured on Fox News 10 Discussing Spravato (esketamine) We had a great time discussing the latest news about the FDA’s recommended approval of Spravato (esketamine) for adults with treatment resistant depression with FOX News 10. Physician Dr. Mark Murphy sat down with Fox News 10 correspondent Nicole Garcia, to discuss what we do at KWC …
KWC featured on Fox News 10 Discussing Spravato (esketamine) Read More »
One thing that raised the eyebrows of everybody on the clinical team here at KWC relates to the recommended dosing of Spravato. On this episode, we discuss what the recommended dosing is during the stabilization and maintenance treatment phases. Is the dosing variable from patient to patient or fixed? What are the implications of utilizing a non-variable prescription for dosing?
This episode focuses on the cost of Spravato to the provide, end user, and insurer. What are the preliminary cost estimates for Spravato (wholesale)? Can we estimate the cost to the patient? Will insurance cover the drug? How will the treatment schedule effect the cost?
THE GREATEST BREAKTHROUGH IN 30 YEARS FOR THE TREATMENT OF TREATMENT RESISTANT DEPRESSION IS SPRAVATO / ESKETAMINE! Is it really? Or are they just confirming what we have known for the last eight years? Yes, finally Johnson and Johnson has successfully received FDA approval to provide the medical community with a new ketamine metabolite …
This episode focuses on how Spravato is administered. Is intranasal delivery effective? What type of clinical environments can provide Spravato to patients? What duration of time will patients have to commit to treatment?
On February 12, 2019 the FDA advisory committee recommended approval of Spravato (esketamine) for adults with treatment resistant depression. Hallelujah! The first new therapy in 30 years for patients suffering from this affliction, or is it?
It’s estimated more than 70% of the United States population owns a pet. Pets add so much value to our lives, mentally, physically, and emotionally. But is there any real evidence supporting what so many pet owners already know? Zooeiya is a new term coined from ongoing research of the health benefits of interacting with …
How many of you have heard from family, friends, or significant others, “Well, you look fine to me,” “Stop being so dramatic!” or “Snap out of it! You just need to exercise and eat right, and you’ll be fine.” It’s true, many people can’t understand the deep and desperate struggles we face on a daily …
WebMD Health News has produced a well-researched piece entitled “Ketamine: A ‘Lifesaving’ Aid for Depression?“. It’s worth reading to get a broad look at the entire Ketamine playing field, featuring interviews with mental health professionals, Ketamine infusion providers, and those hoping for FDA approval of non-infusion medications or vehicles for Ketamine. While there are many …
WebMD Health News Investigates Ketamine’s Popularity in the Treatment of Depression Read More »
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only.
© 2023 Ketamine Wellness Centers
